Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
dsm-firmenich is a global leader in nutrition, health, and beauty, created through the merger of Royal DSM and Firmenich in 2023. The company operates at the intersection of biology, chemistry, and data science to provide innovative ingredients and solutions for the food, beverage, pharmaceutical, and personal care industries. Its extensive portfolio includes vitamins, nutritional lipids, enzymes, probiotics, and high-performance biomedical materials. With a strong focus on sustainability and biotechnology, dsm-firmenich addresses global challenges such as climate change and nutritional security through bio-based production and precision nutrition. The company is a major supplier of active pharmaceutical ingredients (APIs) and excipients, particularly in the field of vitamins and lipids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DSM International.